{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,4]],"date-time":"2026-09-04T23:43:11Z","timestamp":1788565391098,"version":"build-2803163510"},"reference-count":28,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2015,12,22]],"date-time":"2015-12-22T00:00:00Z","timestamp":1450742400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Jpn J Radiol"],"published-print":{"date-parts":[[2016,2]]},"DOI":"10.1007\/s11604-015-0513-3","type":"journal-article","created":{"date-parts":[[2015,12,22]],"date-time":"2015-12-22T08:58:14Z","timestamp":1450774694000},"page":"117-124","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":19,"title":["Revised FIGO staging system for cancer of the ovary, fallopian tube, and peritoneum: important implications for radiologists"],"prefix":"10.1007","volume":"34","author":[{"given":"Tsukasa","family":"Saida","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yumiko Oishi","family":"Tanaka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Koji","family":"Matsumoto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Toyomi","family":"Satoh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiroyuki","family":"Yoshikawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manabu","family":"Minami","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2015,12,22]]},"reference":[{"key":"513_CR1","doi-asserted-by":"crossref","first-page":"2893","DOI":"10.1002\/ijc.25516","volume":"127","author":"J Ferlay","year":"2010","unstructured":"Ferlay J, Shin HR, Bray F, Forman D, Mathers C, Parkin DM. Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008. Int J Cancer. 2010;127:2893\u2013917.","journal-title":"Int J Cancer"},{"issue":"Suppl 1","key":"513_CR2","first-page":"S163","volume":"95","author":"APM Heintz","year":"2006","unstructured":"Heintz APM, Odicino F, Maisonneuve P, Quinn MA, Benedet JL, Creasman WT, et al. Carcinoma of the ovary. Int J Gynecol Obstet. 2006;95(Suppl 1):S163.","journal-title":"Int J Gynecol Obstet"},{"key":"513_CR3","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.ijgo.2013.10.001","volume":"124","author":"J Prat","year":"2014","unstructured":"Prat J, FIGO Committee on Gynecologic Oncology. Staging classification for cancer of the ovary, fallopian tube, and peritoneum. Int J Gynaecol Obstet. 2014;124:1\u20135.","journal-title":"Int J Gynaecol Obstet"},{"key":"513_CR4","first-page":"11","volume-title":"WHO classification of tumours of female reproductive organs","author":"RJ Kurman","year":"2014","unstructured":"Kurman RJ, Carcangiu ML, Herrington S, Young RH. WHO classification of tumours of female reproductive organs. 4th ed. Lyon: IARC Press; 2014. p. 11\u201386.","edition":"4"},{"key":"513_CR5","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1007\/s00428-012-1203-5","volume":"460","author":"J Prat","year":"2012","unstructured":"Prat J. Ovarian carcinoma: five distinct disease with different origins, genetic alterations, and clinicopathological features. Virchows Arch. 2012;460:237\u201349.","journal-title":"Virchows Arch"},{"key":"513_CR6","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1097\/PAS.0b013e3181cf3d79","volume":"34","author":"RJ Kurman","year":"2010","unstructured":"Kurman RJ, Shih IeM. The origin and pathogenesis of epithelial ovarian cancer: a proposed unifying theory. Am J Surg Pathol. 2010;34:433\u201343.","journal-title":"Am J Surg Pathol"},{"key":"513_CR7","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1148\/rg.313105066","volume":"31","author":"N Lalwani","year":"2011","unstructured":"Lalwani N, Prasad SR, Vikram R, Shanbhogue AK, Huettner PC, Fasih N. Histologic, molecular, and cytogenetic features of ovarian cancers: implications for diagnosis and treatment. Radiographics. 2011;31:625\u201346.","journal-title":"Radiographics"},{"key":"513_CR8","doi-asserted-by":"crossref","first-page":"1213","DOI":"10.1016\/j.humpath.2009.04.017","volume":"40","author":"CB Gilks","year":"2009","unstructured":"Gilks CB, Prat J. Ovarian carcinoma pathology and genetics: recent advances. Hum Pathol. 2009;40:1213\u201323.","journal-title":"Hum Pathol"},{"key":"513_CR9","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1038\/nrc2946","volume":"10","author":"DD Bowtell","year":"2010","unstructured":"Bowtell DD. The genesis and evolution of high-grade serous ovarian cancer. Nat Rev Cancer. 2010;10:803\u20138.","journal-title":"Nat Rev Cancer"},{"key":"513_CR10","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1002\/jmri.22430","volume":"33","author":"YO Tanaka","year":"2011","unstructured":"Tanaka YO, Okada S, Satoh T, Matsumoto K, Oki A, Nishida M, et al. Ovarian serous surface papillary borderline tumors form sea anemone-like masses. J Magn Reson Imaging. 2011;33:633\u201340.","journal-title":"J Magn Reson Imaging"},{"key":"513_CR11","doi-asserted-by":"crossref","first-page":"1898","DOI":"10.2214\/ajr.184.6.01841898","volume":"184","author":"SH Kim","year":"2005","unstructured":"Kim SH, Yang DM, Kim SH. Borderline serous surface papillary tumor of the ovary: MRI characteristics. AJR Am J Roentgenol. 2005;184:1898\u2013900.","journal-title":"AJR Am J Roentgenol"},{"key":"513_CR12","doi-asserted-by":"crossref","first-page":"1859","DOI":"10.1002\/1097-0142(19940401)73:7<1859::AID-CNCR2820730714>3.0.CO;2-L","volume":"73","author":"DA Bell","year":"1994","unstructured":"Bell DA, Scully RE. Early de novo ovarian carcinoma. A study of fourteen cases. Cancer. 1994;73:1859\u201364.","journal-title":"Cancer"},{"key":"513_CR13","doi-asserted-by":"crossref","first-page":"923","DOI":"10.2214\/ajr.183.4.1830923","volume":"183","author":"H Morita","year":"2004","unstructured":"Morita H, Aoki J, Taketomi A, Sato N, Endo K. Serous surface papillary carcinoma of the peritoneum: clinical, radiologic, and pathologic findings in 11 patients. AJR Am J Roentgenol. 2004;183:923\u20138.","journal-title":"AJR Am J Roentgenol"},{"issue":"Suppl 1","key":"513_CR14","doi-asserted-by":"crossref","first-page":"S161","DOI":"10.1016\/S0020-7292(06)60033-7","volume":"95","author":"AP Heintz","year":"2006","unstructured":"Heintz AP, Odicino F, Maisonneuve P, Quinn MA, Benedet JL, Creasman WT, et al. Carcinoma of the ovary: FIGO 26th annual report on the results of treatment in gynecological cancer. Int J Gynecol Obstet. 2006;95(Suppl 1):S161\u201392.","journal-title":"Int J Gynecol Obstet"},{"key":"513_CR15","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1111\/j.1525-1438.2007.01058.x","volume":"18","author":"AV Yemelyanova","year":"2008","unstructured":"Yemelyanova AV, Cosin JA, Bidus MA, Boice CR, Seidman JD. Pathology of stage I versus stage III ovarian carcinoma with implications for pathogenesis and screening. Int J Gynecol Cancer. 2008;18:465\u20139.","journal-title":"Int J Gynecol Cancer"},{"key":"513_CR16","doi-asserted-by":"crossref","first-page":"1555","DOI":"10.1002\/(SICI)1097-0142(19981015)83:8<1555::AID-CNCR10>3.0.CO;2-R","volume":"83","author":"T Onda","year":"1998","unstructured":"Onda T, Yoshikawa H, Yasugi T, Mishima M, Nakagawa S, Yamada M, et al. Patients with ovarian carcinoma upstaged to stage III after systematic lymphadenctomy have similar survival to Stage I\/II patients and superior survival to other Stage III patients. Cancer. 1998;83:1555\u201360.","journal-title":"Cancer"},{"key":"513_CR17","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1006\/gyno.1999.5349","volume":"73","author":"K Kanazawa","year":"1999","unstructured":"Kanazawa K, Suzuki T, Tokashiki M. The validity and significance of substage IIIC by node involvement in epithelial ovarian cancer: impact of nodal metastasis on patient survival. Gynecol Oncol. 1999;73:237\u201341.","journal-title":"Gynecol Oncol"},{"key":"513_CR18","doi-asserted-by":"crossref","first-page":"560","DOI":"10.1093\/jnci\/dji102","volume":"97","author":"PB Panici","year":"2005","unstructured":"Panici PB, Maggioni A, Hacker N, Landoni F, Ackermann S, Campagnutta E, et al. Systematic aortic and pelvic lymphadenectomy versus resection of bulky nodes only in optimally debulked advanced ovarian cancer: a randomized clinical trial. J Natl Cancer Inst. 2005;97:560\u20136.","journal-title":"J Natl Cancer Inst"},{"key":"513_CR19","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1016\/j.ygyno.2006.08.047","volume":"103","author":"WA Cliby","year":"2006","unstructured":"Cliby WA, Aletti GD, Wilson TO, Podratz KC. Is it justified to classify patients to Stage IIIC epithelial ovarian cancer based on nodal involvement only? Gynecol Oncol. 2006;103:797\u2013801.","journal-title":"Gynecol Oncol"},{"key":"513_CR20","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1016\/j.ygyno.2007.05.016","volume":"107","author":"G Ferrandina","year":"2007","unstructured":"Ferrandina G, Scambia G, Legge F, Petrillo M, Salutari V. Ovarian cancer patients with \u201cnode-positive-only\u201d Stage IIIC disease have a more favorable outcome than Stage IIIA\/B. Gynecol Oncol. 2007;107:154\u20136.","journal-title":"Gynecol Oncol"},{"key":"513_CR21","doi-asserted-by":"crossref","first-page":"223","DOI":"10.3802\/jgo.2008.19.4.223","volume":"19","author":"SJ Baek","year":"2008","unstructured":"Baek SJ, Park JY, Kim DY, Kim JH, Kim YM, Kim YT, et al. Stage IIIC epithelial ovarian cancer classified solely by lymph node metastasis has a more favorable prognosis than other types of stage IIIC epithelial ovarian cancer. J Gynecol Oncol. 2008;19:223\u20138.","journal-title":"J Gynecol Oncol"},{"key":"513_CR22","doi-asserted-by":"crossref","first-page":"2773","DOI":"10.1007\/s00330-010-1886-4","volume":"20","author":"R Forstner","year":"2010","unstructured":"Forstner R, Sala E, Kinkel K, Spencer JA. ESUR guidelines: ovarian cancer staging and follow-up. Eur Radiol. 2010;20:2773\u201380.","journal-title":"Eur Radiol"},{"key":"513_CR23","doi-asserted-by":"crossref","first-page":"822","DOI":"10.1016\/j.jacr.2013.07.017","volume":"10","author":"DG Mitchell","year":"2013","unstructured":"Mitchell DG, Javitt MC, Glanc P, Bennett GL, Brown DL, Dubinsky T, et al. American College of Radiology. ACR appropriateness criteria staging and follow-up of ovarian cancer. J Am Coll Radiol. 2013;10:822\u20137.","journal-title":"J Am Coll Radiol"},{"key":"513_CR24","doi-asserted-by":"crossref","first-page":"1002","DOI":"10.1016\/j.ejrad.2011.01.112","volume":"81","author":"Y Yuan","year":"2012","unstructured":"Yuan Y, Gu ZX, Tao XF, Liu SY. Computer tomography, magnetic resonance imaging, and positron emission tomography or positron emission tomography\/computer tomography for detection of metastatic lymph nodes in patients with ovarian cancer: a meta-analysis. Eur J Radiol. 2012;81:1002\u20136.","journal-title":"Eur J Radiol"},{"key":"513_CR25","doi-asserted-by":"crossref","first-page":"1912","DOI":"10.1007\/s00259-008-0890-2","volume":"35","author":"K Kitajima","year":"2008","unstructured":"Kitajima K, Murakami K, Yamasaki E, Kaji Y, Fukasawa I, Inaba N, et al. Diagnostic accuracy of integrated FDG-PET\/contrast-enhanced CT in staging ovarian cancer: comparison with enhanced CT. Eur J Nucl Med Mol Imaging. 2008;35:1912\u201320.","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"513_CR26","doi-asserted-by":"crossref","first-page":"943","DOI":"10.1056\/NEJMoa0908806","volume":"363","author":"I Vergote","year":"2010","unstructured":"Vergote I, Trop\u00e9 CG, Amant F, Kristensen GB, Ehlen T, Johnson N, et al. Neoadjuvant chemotherapy or primary surgery in stage IIIC or IV ovarian cancer. N Engl J Med. 2010;363:943\u201353.","journal-title":"N Engl J Med"},{"key":"513_CR27","doi-asserted-by":"crossref","first-page":"1397","DOI":"10.1002\/cncr.20920","volume":"103","author":"R Eitan","year":"2005","unstructured":"Eitan R, Levine DA, Abu-Rustum N, Sonoda Y, Huh JN, Franklin CC, et al. The clinical significance of malignant pleural effusions in patients with optimally debulked ovarian carcinoma. Cancer. 2005;103:1397\u2013401.","journal-title":"Cancer."},{"key":"513_CR28","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/j.ygyno.2008.09.010","volume":"112","author":"GD Aletti","year":"2009","unstructured":"Aletti GD, Podratz KC, Cliby WA, Gostout BS. Stage IV ovarian cancer: disease site-specific rationale for postoperative treatment. Gynecol Oncol. 2009;112:22\u20137.","journal-title":"Gynecol Oncol"}],"container-title":["Japanese Journal of Radiology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11604-015-0513-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s11604-015-0513-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11604-015-0513-3","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,6,1]],"date-time":"2019-06-01T17:29:01Z","timestamp":1559410141000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s11604-015-0513-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,12,22]]},"references-count":28,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2016,2]]}},"alternative-id":["513"],"URL":"https:\/\/doi.org\/10.1007\/s11604-015-0513-3","relation":{},"ISSN":["1867-1071","1867-108X"],"issn-type":[{"value":"1867-1071","type":"print"},{"value":"1867-108X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,12,22]]}}}